RecruitingNCT04192825
Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
Sponsor
Rennes University Hospital
Enrollment
440 participants
Start Date
Feb 3, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Determine the optimal therapeutic combination associated with complete clinical and anatomical remission of anal suppurations of Crohn's disease at 12 months.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Persons over 18 years of age
- People suffering from anal suppuration of Crohn's disease for whom a drainage procedure is planned.
- Person who has received written and oral information about the protocol and has not expressed opposition to participate in the study.
Exclusion Criteria4
- No one who is unable to have an anesthetic, structural or psychological examination by MRI and/or surgery.
- Person planning a planned absence that could hinder participation in the research (travel abroad, relocation, impending transfer);
- Person with an associated pathology that is a priority for care;
- Vulnerable person (minors, persons under guardianship or curatorship, or deprived of their liberty by a judicial or administrative decision
Interventions
PROCEDUREsurgical treatment
surgical drainage and/or surgical reconstruction procedures to anoperineal suppurations according to the doctor's decision
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04192825
Related Trials
Combined Immunosuppression for Pediatric Crohn's Disease
NCT050438701 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
NCT073100954 locations
Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy
NCT068560442 locations
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
NCT043721081 location